Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Merck Sharp & Dohme LLC
Age
0–0
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Healthy (based on a review of medical history and physical examination) based on the clinical judgment of the investigator
Male or female approximately 2 months of age, from 42 days to 90 days inclusive, at the time of obtaining the informed consent
Have a legally acceptable representative who understands the study procedures, alternate treatments available, and risks involved with the study and voluntarily agrees to participate by giving written informed consent.
You may not be if
History of Invasive Pneumococcal Disease (IPD) (positive blood culture, positive cerebrospinal fluid culture, or other sterile site) or known history of other culture positive pneumococcal disease
Known hypersensitivity to any component of the pneumococcal conjugate vaccine (PCV) or any diphtheria toxoid containing vaccine
Known or suspected impairment of immunological function
History of congenital or acquired immunodeficiency
Has or his/her mother has a documented human immunodeficiency virus (HIV) infection
Known or history of functional or anatomic asplenia
Failure to thrive based on the clinical judgment of the investigator
Known coagulation disorder contraindicating intramuscular vaccination
History of autoimmune disease (including but not limited to systemic lupus erythematosus, antiphospholipid syndrome, Behcet's disease, autoimmune thyroid disease, polymyositis and dermatomyositis, scleroderma, type 1 diabetes mellitus, or other autoimmune disorders)
Known neurologic or cognitive behavioral disorder, including encephalitis/myelitis, acute disseminating encephalomyelitis, pervasive development disorder, and related disorders
Received a dose of any pneumococcal vaccine prior to study entry
Received a blood transfusion or blood products, including immunoglobulins, before receipt of first dose of study vaccine
Participated in another clinical study of an investigational product before the beginning or anytime during the duration of the current clinical study. Participants enrolled in observational studies may be included.
Has any other reason that, in the opinion of the investigator, may interfere with the evaluation required by the study
Has an immediate family member who is investigational site or Sponsor staff directly involved with this study.
Clareo Health | A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)
